Yüklüyor......
Comparative assessment of platelet Gp(IIb/IIIa) receptor occupancy ratio with Eptifibatide/Tirofiban in patients presenting with ACS and undergoing PCI
BACKGROUND: The level of platelet inhibition by a Glycoprotein IIb/IIIa (Gp(IIb/IIIa)) antagonist therapy necessary to minimize thrombotic complications in patients undergoing percutaneous coronary intervention (PCI) is a subject of debate. The degree of platelet inhibition obtained 10 min after sta...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861195/ https://ncbi.nlm.nih.gov/pubmed/23647894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.08.007 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|